Virtual group writing program for young cancer survivors
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
This study is testing a virtual writing program to see if it can help young cancer survivors feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06434402 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of a virtual, group-based expressive writing intervention aimed at improving the quality of life for adolescent and young adult cancer survivors. Participants, aged 18-39 and within five years of their cancer diagnosis, will engage in writing exercises designed to express their experiences and emotions related to their cancer journey. The study also seeks to preliminarily assess the impact of this intervention on participants' well-being. The program is conducted online, allowing for flexible participation.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18-39 who have completed treatment for stage II-IV cancer within the last five years.
Not a fit: Patients with major mental health disorders or those without internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance the emotional well-being and quality of life for young cancer survivors.
How similar studies have performed: Other studies have shown positive outcomes with expressive writing interventions for various populations, suggesting potential success for this approach in cancer survivors.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Age 15 - 39 years at cancer diagnosis * Age 18 - 39 years at study entry * Diagnosed between 1 and 5 years ago prior to enrollment * Can speak, read, and write in English Exclusion criteria: * Nonmelanoma skin cancer * Major mental health disorder (e.g., schizophrenia or bipolar disorder \[determined from patient records or self-disclosure\]) * No internet access.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Qian Lu, MD,PHD — M.D. Anderson Cancer Center
- Study coordinator: Qian Lu, MD,PHD
- Email: qlu@mdanderson.org
- Phone: (713) 745-8324
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.